A SYSTEMIC REVIEW:ERRORS IN INHALER USE INTRODUCTION
Main Article Content
Keywords
Abstract
Inhalation therapy is the cornerstone of successful management of obstructive airway diseases (OADs) such as asthma and chronic obstructive pulmonary disease (COPD) due to its two-fold benefits – drug delivery to the target organ, and less systemic exposure with minimal adverse effects on other organs.Different types of inhaler devices such as pressurized metered-dose inhalers (pMDIs) with or without spacers, dry powder inhalers (DPIs), breath-actuated inhalers (BAIs) and nebulizers are available, which provide the physician and the patient the opportunity to select/use a device based on the ability of patients and preference of patient and physicians. Despite this, most physicians report poor inhaler technique and non-adherence to inhaler devices among their patients, which can result in a high economic burden on healthcare cost and utilization, both directly and indirectly, involving exacerbations, increased hospitalizations/hospital visits, poor quality of life and increased morbidity and mortality[31]
References
2. Giraud V,Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. EurRespir J 2002;19:246-51.
3. Lareau SC, Hodder R. Teaching inhaler use in chronic obstructive pulmonary disease patients. J Am Acad Nurse Pract 2012;24:113-20.
4. Molimard M, RaherisonC, LignotS,et. Al. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003;16:249-54.
5. LarsenJS, Hahn M, Ekholm B, Wick KA. Evolution of conventional press-and-breathe metered-dose inhaler technique in 501 patients. J Asthma 1994;31:193-9.
6. Thompson J, Irvine T, Grathwohl K, Roth B. Misuse of metered-dose inhalers in hospitalized patients. Chest 1994;105:715-7
7. Vaswani SK, Creticos PS. Metered dose inhaler : past, present and future. Ann Allergy Asthma Immunol 1998;80:11-21.
8. KhassawnehBasheer Y, AlzoubiKarem H, BatarsehMorad Z, et.al. Handling of inhalers in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers. Respir Care 2008;53:324-8.
9. Souza ML, Meneghini AC,Ferraz E, Knowledge of and technique for using inhalation devices among asthma patients and COPD patients. J Bras Pneumol 2009 Sep;35:824-31.
10. PlazaV, Sanchis J. Medical personnel and patient skill in the use of metered dose inhalers: a multicentricstudy . CESEA Group . Respiration 1998; 65:195-8.
11. Van Der Palen J, Klein JJ, KerkhoffAH,et.al. Evaluation of the long-term effectiveness of three instruction modes for inhaling medicines. Patient EducCouns 1997;32(Suppl.): S87-S95.
12. Lindgren S, Bake B, Larsson S. Clinical consequences of inadequate inhalation technique in asthma therapy. Eur J Respir Dis 1987; 70:93-8.
13. Grant EN, Turner-Roan K, Daugherty SR, et al. Development of a survey of asthma knowledge, attitudes and perception: The Chicago Community Asthma Survey. Chicago Asthma Surveillance Initiative Project Team. Chest 1999;116:178-83S.
14. Van Sickle D, Wright AL. Navajo perceptions of asthma and asthma medications: Clinical implications. Pediatrics 2001;108:E11.
15. Melani AS, Zanchetta D, Barbato N, et al. Inhalation technique and variables associated with misuse of conventionl metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol. 2004;93:439-46.
16. Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of pharmacist intervention for asthma control improvement ,EurRespir J. 2008;31:790-99.
17. Van der Palen J, Klein JJ, SchildcampAM.Comparison of a new multi-dose powder inhaler(Diskus/Accuhaler) and the Turbuhaler regarding preferences and ease of use. J.Asthma. 1998;35:147-52.
18. Hesselink AE, Penninx BW, van der Windt DA, et al. Effectiveness of an education programme by a general practice assistant for asthma and COPD patients: results from a randomized controlled trial. Patient EducCouns. 2004;55:121-28.
19. Lenney J, Innes JA, Crompton GK.Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med. 2000;94:496-500.
20. Sodhi R, Prasad R, Kushwaha R, Kant S, Verma SK, Garg R, et al. A study to know the knowledge, attitude,and practices of patients of bronchial asthma. Int J Med Public Health 2013;3:159-62.
21. Prasad R, Gupta R, Verma, S.K .A Study on Perception of Patients about Bronchial AsthmaIndian J Allergy Asthma Immunol 2003; 17 : 85-87.
22. PiyushArora, Lokender Kumar*, VikramVohra, et.al.Evaluating the technique of using inhalation
device in COPD and Bronchial Asthmapatients.Respiratory Medicine (2014) 108, 992-998
23. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient
24. compliance, devices, and inhalationtechnique. Chest. 2000;117:542.
25. De Blaquiere P, Christensen DB,Carter WB, Martin TR. Use and misuse of metered-dose inhalers by patients withchronic lung disease. Am Rev Respir Dis.1989;140:910-916..
26. Nimmo CJR, Chen DNM, Martinusen SM, Ustad TL, Ostrow DN. Assessment of patient acceptance andinhalation technique of a pressurized aerosol inhaler and two breath-actuated devices. Ann Pharmacother. 1993;27:922-927.
27. Press VG, Arora VM, Shah LM, et al. Misuse of respiratory inhalers in hospitalized patients with asthma orCOPD. J Gen Intern Med. 2011;26: 635-642.
28. Duerden M, Price D. Training issues in the use of inhalers. Dis Manage Health Outcomes. 2001;9:75-87.
29. Van der Palen J, Klein JJ, Kerkhoff AH, van Herwaarden CL, Seydel ER. Evaluation of the long-term effectivenessof three instruction modes for inhaling medicines. Patient EducCouns. 1997;3:S87-S95.
30. Sanchis J, GichI ,Pedersen S. Systematic Review of Errors in Inhaler Use Has Patient Technique Improved Over Time? CHEST 2016; 150(2):394-406
31. BalamuruganaS ,Apteb K, Singh B P,Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a Pmdi. Respiratory Medicine 161 (2020) 105707.
32. Balamurugan S, Dalal S, Deshmukh V. Effectiveness and safety of salmeterol/ fluticasone fixed-dose combination delivered through Synchrobreathe® in patients with asthma: the real-world EVOLVE study. TherAdvRespir Dis 2022, Vol. 16: 1–13 . 2015.1050499

